Abstract
The population of the Middle East is a growing population characterized by increasing prevalence of metabolic syndrome, diabetes, and obesity. Bothmyocardial perfusion imaging (MPI) and coronary artery calcification (CAC) have a well-validated role in the diagnosis and prognosis of coronary artery disease (CAD). In the recent years, adding CAC score to myocardial perfusion imaging has been associated with incremental diagnostic and prognostic value. The aim of this paper is to review the diagnostic and prognostic value of adding CAC score to nuclear MPI in the Middle Eastern patients in the face of increasing prevalence of metabolic syndrome and CAD risk factors. Since limited local data are available from the Middle East, this review will focus on reports on similar cohorts from the western world.